InVivo Therapeutics Chooses Richard Toselli for CEO Post

Richard Toselli has been named president and CEO of InVivo Therapeutics (NASDAQ: [[ticker:NVIV]]). Toselli had been acting CEO of the Cambridge, MA, medical device developer since December. Toselli will also continue as the company’s chief medical officer, a role the neurosurgeon took on when he joined InVivo last July. InVivo’s technology was co-invented by MIT professor Robert Langer. The company’s medical device, an implantable spinal scaffold for spinal cord injuries, is being tested in a clinical trial.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.